Oncolytics Biotech Inc. (ONCY)

[Noodle2]

Oncolytics Biotech® Inc. Announces Details of 2017 Annual Meeting of Shareholders

"CALGARY, April 27, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (Oncolytics or the Company) (ONC.TO) (ONCYF) announced today that its 2017 Annual Meeting of Shareholders will be held on Thursday, May 4th, 2017 at 4:00 pm ET (2:00 pm MT) at the Toronto Region Board of Trade located at First Canadian Place, Suite 350, 77 Adelaide Street West, Toronto, Ontario.

Following the business portion of the meeting, Dr. Matt Coffey, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN®, including recent randomized phase 2 metastatic breast cancer results as well as the detailed clinical development plan and specific initial registration pathway for REOLYSIN.

A live audio webcast of Dr. Coffey's presentation will begin at approximately 4:15 pm ET (2:15 pm MT) and be available at http://event.on24.com/r.htm?e=1415093&s=1&k=1D9EC98BC2D829CD19D1A85F7769DEAC and on the company's website at http://www.oncolyticsbiotech.com/investor-centre/presentations. It is recommended that listeners log on 10 minutes in advance of a live session to register and download any necessary software. An audio replay will be accessible approximately two hours following the presentation on the Oncolytics website."

https://finance.yahoo.com/news/oncolytics-biotech-inc-announces-details-110000855.html